Case Report: Can Chronic Relapsing Multifocal Osteomyelitis (CRMO) Be Combined With Hematologic Neoplasms?
- 23 May 2025
- journal article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 28 (5) , e70294
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China
This publication has 11 references indexed in Scilit:
- Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and managementAmerican Journal of Hematology, 2024
- JAKi: Can it be used to treat SAPHO syndrome?International Journal of Rheumatic Diseases, 2023
- Molecular interactions of adaptor protein PSTPIP2 control neutrophil-mediated responses leading to autoinflammationFrontiers in Immunology, 2022
- Inflammation Promotes Oxidative and Nitrosative Stress in Chronic Myelogenous LeukemiaBiomolecules, 2022
- The receptor-type protein tyrosine phosphatase CD45 promotes onset and severity of IL-1β–mediated autoinflammatory osteomyelitisJournal of Biological Chemistry, 2021
- Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO)Journal of Translational Autoimmunity, 2021
- The role of JAK/STAT signaling pathway and its inhibitors in diseasesInternational Immunopharmacology, 2020
- Understanding the Multifaceted Role of Neutrophils in Cancer and Autoimmune DiseasesFrontiers in Immunology, 2018
- Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and TreatmentCurrent Osteoporosis Reports, 2017
- Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemiaHaematologica, 2017